Sildenafil Tablet
Product Images NDC 71335-1963

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 71335-1963). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351963)

Label (Lbl713351963)
Description: The text appears to be a label of medication named Sildenafil Citrate, also known as Revatio. It is a 20mg tablet manufactured by Ajanta Pharma Limited. The label provides instructions to keep the drug out of the reach of children and store it in 20°-25°C temperature. The label also states the NDC code and expiration date of the medication.*
FDA Label Image

Figure1 (Sildenafil Figure 1)

Figure1 (Sildenafil Figure 1)
This appears to be a chart or graph displaying different doses over time, but it is not clear what substance or treatment is being measured. Therefore, a useful description cannot be generated with this text alone.*
FDA Label Image

Sildenafil_fig2 (Sildenafil Figure 2)

FDA Label Image

Figure3 (Sildenafil Figure 3)

FDA Label Image

Figure4 (Sildenafil Figure 4)

Figure4 (Sildenafil Figure 4)
This appears to be a table showing the change in mefers at different time points during a study. The different treatment groups are listed on the right side with varying doses of sildenafil administered three times a day. The left column shows the different weeks of the study. However, without additional context or information, it is difficult to determine the precise nature or purpose of the study.*
FDA Label Image

Figure5 (Sildenafil Figure 5)

Figure5 (Sildenafil Figure 5)
This appears to be a medical report including data on a study of individuals with Idiopathic PAH, CTD-related PAH, and PAH after surgical repair. The report includes walk distance measurements, functional capacity, gender, age, and median PAP data. Additionally, it mentions the use of placebo and Sildenafil 20mg for treatment (TID).*
FDA Label Image

Figure6 (Sildenafil Figure 6)

FDA Label Image

Sildenafil-figure-7 (Sildenafil Figure 7)

Sildenafil-figure-7 (Sildenafil Figure 7)
Not available. The text seems to be incomplete and does not provide adequate information to generate a useful description.*
FDA Label Image

Structure (Sildenafil Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.